Similarly, AMD31100 coated on synthetic protein nanoparticles (AMD3100-SPNPs) delivered to a glioblastoma mouse model inhibited tumor proliferation and reduced infiltration of CXCR4+ MDSCs while overcoming poor pharmacokinetic properties of AMD3100 and restoring the blood-brain barrier (138). Here, CXCR4 is linked to neoplasm.